NCT04003935 is a clinical trial of Juice Plus+ Complete in Overweight or Obesity, sponsored by Green Beat.

Who is sponsoring NCT04003935?

NCT04003935 is sponsored by Green Beat.

What drugs are being tested in NCT04003935?

Interventions in NCT04003935: Juice Plus+ Complete, Juice Plus+ Premium.

What condition does NCT04003935 study?

NCT04003935 studies Overweight or Obesity.

Is NCT04003935 still recruiting?

NCT04003935 is currently terminated. Last updated 29 May 2020.

Last reviewed 2020-05-29 · How we verify

NCT04003935

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Juice Plus Inflammaging and Cardiovascular Disease Prevention Study

Terminated Last updated 29 May 2020

What this trial tests

trial testing Juice Plus+ Complete in Overweight or Obesity in 22 participants. Terminated before completion.

Timeline

1 June 2019

Primary endpoint
27 May 2020

27 May 2020

Quick facts

Lead sponsor	Green Beat
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	22
Start date	1 June 2019
Primary completion	27 May 2020
Estimated completion	27 May 2020
Sites	2 locations across Austria

Drugs / interventions tested

Juice Plus+ Complete
Juice Plus+ Premium

Conditions studied

Overweight or Obesity — all drugs for Overweight or Obesity →

Sponsor

Green Beat

Who can join

Adults 50 to 80, any sex, with Overweight or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low- grade inflammation is a pathological feature of a wide range of chronic conditions, including the metabolic syndrome, cardiovascular diseases (CVD) and the accelerated reduction in bone density. Previous research shows that diets rich in fruits and vegetables can reduce chronic inflammation. To date there is no data on multiyear clinical interventions assessing the effect of plant-based dietary supplements on low-grade inflammation, cardiovascular disease prevention and indicators of biological aging, including individuals' cognitive function. In this study, the investigators are thus exploring whether separate ingestions of two plant-based nutritional products over 2 years, are able to modulate low-grade inflammation, parameters of CVD prevention, circulating micronutrients, upper respiratory tract- and gastro-intestinal symptoms, quality of life, indicators of biological aging, and cognitive function in overweight seniors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery.
Chakhtoura MT, Nakhoul NF, Akl EA, Safadi BY, et al · · 2024 · cited 4× · PMID 39351881 · DOI 10.1002/14651858.cd011800.pub2

Verify or expand the search:

Other recruiting trials for Overweight or Obesity

Currently open trials in the same condition.

NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
NCT07431086 — Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US · Phase 2 · recruiting
NCT07294235 — A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants · Phase 1 · recruiting
NCT07224399 — Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multi · Phase 1 · recruiting
NCT07170319 — A Study of IBI3032 in Chinese Participants With Overweight or Obesity · Phase 1 · active not recruiting

Other Green Beat trials

Trials by the same sponsor.

NCT03348553 — Juice Plus+OMEGA Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04003935 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Green Beat
Last refreshed: 29 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04003935.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing